129 related articles for article (PubMed ID: 29346782)
21. Section 5. Further expanding the criteria for HCC in living donor liver transplantation: when not to transplant: SNUH experience.
Lee KW; Yi NJ; Suh KS
Transplantation; 2014 Apr; 97 Suppl 8():S20-3. PubMed ID: 24849825
[TBL] [Abstract][Full Text] [Related]
22. Analysis of the risk factors of untransplantable recurrence after primary curative resection for patients with hepatocellular carcinoma.
Ho CM; Wu CY; Lee PH; Lai HS; Ho MC; Wu YM; Hu RH
Ann Surg Oncol; 2013 Aug; 20(8):2526-33. PubMed ID: 23504121
[TBL] [Abstract][Full Text] [Related]
23. The role of (18)F-FDG-PET imaging for the selection of liver transplantation candidates among hepatocellular carcinoma patients.
Yang SH; Suh KS; Lee HW; Cho EH; Cho JY; Cho YB; Yi NJ; Lee KU
Liver Transpl; 2006 Nov; 12(11):1655-60. PubMed ID: 16964589
[TBL] [Abstract][Full Text] [Related]
24. Younger age and presence of macrovascular invasion were independent significant factors associated with poor disease-free survival in hepatocellular carcinoma patients undergoing living donor liver transplantation.
Wai CT; Woon WA; Tan YM; Lee KH; Tan KC
Transplant Proc; 2012 Mar; 44(2):516-9. PubMed ID: 22410059
[TBL] [Abstract][Full Text] [Related]
25. Patients with non-[18 F]fludeoxyglucose-avid advanced hepatocellular carcinoma on clinical staging may achieve long-term recurrence-free survival after liver transplantation.
Kornberg A; Küpper B; Tannapfel A; Büchler P; Krause B; Witt U; Gottschild D; Friess H
Liver Transpl; 2012 Jan; 18(1):53-61. PubMed ID: 21850692
[TBL] [Abstract][Full Text] [Related]
26. Recurrent hepatocellular carcinoma after transplantation: use of a pathological score on explanted livers to predict recurrence.
Parfitt JR; Marotta P; Alghamdi M; Wall W; Khakhar A; Suskin NG; Quan D; McAllister V; Ghent C; Levstik M; McLean C; Chakrabarti S; Garcia B; Driman DK
Liver Transpl; 2007 Apr; 13(4):543-51. PubMed ID: 17394152
[TBL] [Abstract][Full Text] [Related]
27. Effect of Liver Transplant on Long-term Disease-Free Survival in Children With Hepatoblastoma and Hepatocellular Cancer.
Pham TA; Gallo AM; Concepcion W; Esquivel CO; Bonham CA
JAMA Surg; 2015 Dec; 150(12):1150-8. PubMed ID: 26308249
[TBL] [Abstract][Full Text] [Related]
28. Hepatic resection for transplantable hepatocellular carcinoma for patients within Milan and UCSF criteria.
Chua TC; Saxena A; Chu F; Morris DL
Am J Clin Oncol; 2012 Apr; 35(2):141-5. PubMed ID: 21336092
[TBL] [Abstract][Full Text] [Related]
29. Total tumor volume predicts survival following liver resection in patients with hepatocellular carcinoma.
Li MX; Zhao H; Bi XY; Li ZY; Huang Z; Han Y; Zhou JG; Zhao JJ; Zhang YF; Wei WQ; Zhao DB; Cai JQ
Tumour Biol; 2016 Jul; 37(7):9301-10. PubMed ID: 26779628
[TBL] [Abstract][Full Text] [Related]
30. Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA.
Duffy JP; Vardanian A; Benjamin E; Watson M; Farmer DG; Ghobrial RM; Lipshutz G; Yersiz H; Lu DS; Lassman C; Tong MJ; Hiatt JR; Busuttil RW
Ann Surg; 2007 Sep; 246(3):502-9; discussion 509-11. PubMed ID: 17717454
[TBL] [Abstract][Full Text] [Related]
31. A single-center retrospective analysis of liver transplantation on 255 patients with hepatocellular carcinoma.
Wang ZX; Song SH; Teng F; Wang GH; Guo WY; Shi XM; Ma J; Wu YM; Ding GS; Fu ZR
Clin Transplant; 2010; 24(6):752-7. PubMed ID: 20030683
[TBL] [Abstract][Full Text] [Related]
32. Determination of hepatocellular carcinoma grade by needle biopsy is unreliable for liver transplant candidate selection.
Court CM; Harlander-Locke MP; Markovic D; French SW; Naini BV; Lu DS; Raman SS; Kaldas FM; Zarrinpar A; Farmer DG; Finn RS; Sadeghi S; Tomlinson JS; Busuttil RW; Agopian VG
Liver Transpl; 2017 Sep; 23(9):1123-1132. PubMed ID: 28688158
[TBL] [Abstract][Full Text] [Related]
33. Liver transplantation and recurrent hepatocellular carcinoma: predictive value of nodule size in a retrospective and explant study.
Grasso A; Stigliano R; Morisco F; Martines H; Quaglia A; Dhillon AP; Patch D; Davidson BR; Rolles K; Burroughs AK
Transplantation; 2006 Jun; 81(11):1532-41. PubMed ID: 16770242
[TBL] [Abstract][Full Text] [Related]
34. Liver transplantation for hepatocellular carcinoma in patients beyond the Milan but within the UCSF criteria.
Sotiropoulos GC; Molmenti EP; Omar OS; Bockhorn M; Brokalaki EI; Lang H; Frilling A; Broelsch CE; Malagó M
Eur J Med Res; 2006 Nov; 11(11):467-70. PubMed ID: 17182358
[TBL] [Abstract][Full Text] [Related]
35. Up-to-7 Criteria for Hepatocellular Carcinoma Liver Transplantation: A Retrospective Analysis of Experiences.
León Díaz FJ; Pérez Daga JA; Sánchez Pérez B; Fernández Aguilar JL; Montiel Casado C; Aranda Narváez JM; Suárez Muñoz MA; Romacho López L; Santoyo Villalba J; Santoyo Santoyo J
Transplant Proc; 2016 Nov; 48(9):2969-2972. PubMed ID: 27932121
[TBL] [Abstract][Full Text] [Related]
36. Outcome of Liver Transplantation in Hepatocellular Carcinoma Patients at Siriraj Hospital.
Kositamongkol P; Sanphasitvong V; Sirivatanauksorn Y; Pongpaibul A; Limsrichamrern S; Mahawithitwong P; Asavakarn S; Tovikkai C; Dumronggittigule W
Transplant Proc; 2017 Jun; 49(5):1114-1117. PubMed ID: 28583538
[TBL] [Abstract][Full Text] [Related]
37. Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization.
Green TJ; Rochon PJ; Chang S; Ray CE; Winston H; Ruef R; Kreidler SM; Glueck DH; Shulman BC; Brown AC; Durham J
J Vasc Interv Radiol; 2013 Nov; 24(11):1613-22. PubMed ID: 24060436
[TBL] [Abstract][Full Text] [Related]
38. Significance of preoperative fluorodeoxyglucose-positron emission tomography in prediction of tumor recurrence after liver transplantation for hepatocellular carcinoma patients: a Japanese multicenter study.
Takada Y; Kaido T; Shirabe K; Nagano H; Egawa H; Sugawara Y; Taketomi A; Takahara T; Wakabayashi G; Nakanishi C; Kawagishi N; Kenjo A; Gotoh M; Toyoki Y; Hakamada K; Ohtsuka M; Akamatsu N; Kokudo N; Takeda K; Endo I; Takamura H; Okajima H; Wada H; Kubo S; Kuramitsu K; Ku Y; Ishiyama K; Ohdan H; Ito E; Maehara Y; Honda M; Inomata Y; Furukawa H; Uemoto S; Yamaue H; Miyazaki M; Takada T;
J Hepatobiliary Pancreat Sci; 2017 Jan; 24(1):49-57. PubMed ID: 27806426
[TBL] [Abstract][Full Text] [Related]
39. A computed tomography radiogenomic biomarker predicts microvascular invasion and clinical outcomes in hepatocellular carcinoma.
Banerjee S; Wang DS; Kim HJ; Sirlin CB; Chan MG; Korn RL; Rutman AM; Siripongsakun S; Lu D; Imanbayev G; Kuo MD
Hepatology; 2015 Sep; 62(3):792-800. PubMed ID: 25930992
[TBL] [Abstract][Full Text] [Related]
40. Combination of biological and morphological parameters for the selection of patients with hepatocellular carcinoma waiting for liver transplantation.
Lai Q; Avolio AW; Manzia TM; Sorge R; Agnes S; Tisone G; Berloco PB; Rossi M
Clin Transplant; 2012; 26(2):E125-31. PubMed ID: 22192083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
